Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Recomgen Biotech
company
About
Recomgen Biotech engages in R&D, production and sales of drugs.
- 251 - 500
Highlights
Details
- Last Funding Type
- Angel
- Last Funding Money Raised
- ¥3M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Sales
- Founded date
- Oct 1, 2000
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥43M
Recomgen Biotech has raised a total of
¥43M
in funding over 2 rounds. Their latest funding was raised on
Oct 14, 2019 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 14, 2019 | Series C | ¥30M | 1 |
|
— | Detail |
| Apr 19, 2016 | Series A | ¥10M | 3 | — | — | Detail |
| Oct 24, 2000 | Angel | ¥3M | 4 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
7
Recomgen Biotech is funded by 7 investors.
Zhuhai Zhifan Qiye Guanli
and Lujing Keji Konggu
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series C |
|
|
— | Series A |
Wanlian Tianze
|
— | Series A |
Guangzhou Jinkong Fund
|
— | Series A |
|
|
— | Angel |
|
|
— | Angel |
Youth Team
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
